Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - RETAINED EARNINGS
Retained Earnings KROS - Keros Therapeutics, Inc.
-381 M
LAST VALUE
-75.56%
2 YEAR CAGR
-120.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR